PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MicroRNA molecule found to be a potent tumor-suppressor in lung cancer

2013-09-17
(Press-News.org) COLUMBUS, Ohio – New research shows that microRNA-486 is a potent tumor-suppressor molecule in lung cancer, and that the it helps regulate the proliferation and migration of lung-cancer cells, and the induction of programmed cell death, or apoptosis, in those cells.

The preclinical study was led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). It found that microRNA-486 (miR-486) directly targets the insulin growth-factor pathway, which is important for cell survival and proliferation. Alternations in the pathway are believed to play an early role in tumor initiation and progression.

The researchers further found that miR-486 is itself regulated by the tumor-suppressor gene p53, the most frequently altered gene in human cancers, and that activity of miR-486 is partially dependent upon functional p53.

Published in the Proceedings of the National Academy of Sciences, the study suggests that miR-486 might serve as a biomarker for lung-cancer patients who might respond to treatment with insulin-growth-factor inhibitors.

"It wasn't known whether miR-486 functioned as an oncogene or a tumor-suppressor gene in lung cancer," says co-corresponding author Patrick Nana-Sinkam, MD, associate professor of medicine and a researcher with the OSUCCC – James Molecular Biology and Cancer Genetics Program.

"miR-486 appears to be a biomarker for lung cancer, but its mechanisms of action remain unclear," he says. "These findings show that miR-486 serves a tumor-suppressor function in lung cancer, and that miR-486 action is partially dependent on p53."

"This partial reliance of one tumor-suppressor on another was a surprise," says principal investigator and co-corresponding author Carlo M. Croce, MD, director of Ohio State's Human Cancer Genetics program and the John W. Wolfe Chair in Human Cancer Genetics at the OSUCCC – James. "We don't know yet what implications, if any, this might have for the development of targeted therapies."

MicroRNAs are a class of short, non-coding RNAs that regulate the translation or degradation of messenger RNA and therefore the proteins that cells make. Research is showing that certain microRNAs are frequently dysregulated in cancer.

Nana-Sinkam and his colleagues examined lung-tumor samples from 81 patients with stage-1 nonsmall-cell lung cancer and tumor-cell lines. Analyses identified miR-486 as the most decreased of microRNAs in the cells, so the researchers chose it for further investigation.

INFORMATION:

Funding from the NIH/National Cancer Institute (grant CA152758) supported this research.

Other researchers involved in this study were Yong Peng, Yuntao Dai, Charles Hitchcock, Xiaojuan Yang, Edmund S. Kassis, Zhenghua Luo, Hui-Lung Sun, Ri Cui, Huijun Wei, Taewan Kim, Tae Jin Lee, Young-Jun Jeon, Gerard J. Nuovo, Stefano Volinia, Jianhua Yu and Carlo M. Croce of The Ohio State University; Lunxu Liu of Sichuan University, China; and Qianchuan He of Fred Hutchinson Cancer Research Center.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 228-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S.News & World Report.

END



ELSE PRESS RELEASES FROM THIS DATE:

Heart attacks in young women -- not all have chest pain

2013-09-17
This news release is available in French. Montreal September 17, 2013 – Chest pain is recognized as a symptom of heart troubles, but one out of five women aged 55 years or less having a heart attack do not experience this symptom, according to a study led by the Research Institute of the McGill University Health Centre (RI-MUHC). The research findings, gathered from partner institutions across Canada including the University of British Columbia (UBC), are the first to describe this phenomenon in young women. The study, published in JAMA Internal Medicine, has ...

Why do young adults start smoking?

2013-09-17
The risk of becoming a smoker among young adults who have never smoked is high: 14% will become smokers between the ages of 18 and 24, and three factors predict this behaviour. "Smoking initiation also occurs among young adults, and in particular among those who are impulsive, have poor grades, or who use alcohol regularly," said Jennifer O'Loughlin, a Professor at the University of Montreal School of Public Health (ESPUM) and author of a Journal of Adolescent Health study published in August. O'Loughlin believes smoking prevention campaigns should also target young adults ...

Self-referral spurs unnecessary MRI exams for patients

2013-09-17
OAK BROOK, Ill. – Patients having knee MRI examinations are significantly more likely to receive a negative finding if referred by physicians who have a financial interest in the imaging equipment being used, according to a study published online in the journal Radiology. Imaging self-referral, whereby a non-radiologist physician refers their own patients for imaging to facilities in which they or their partners have a financial interest, is a growing trend in medicine and a significant driver of healthcare costs. Medical imaging self-referral leads to higher utilization ...

New marker identified for early diagnosis of lung cancer

2013-09-17
PHILADELPHIA — A protein called isocitrate dehydrogenase (IDH1) is present at high levels in lung cancers and can be detected in the blood, making it a noninvasive diagnostic marker for lung cancers, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "This study is the first to report identification of IDH1 as a novel biomarker for the diagnosis of non-small cell lung cancers (NSCLC) using a large number of clinical samples," said Jie He, M.D., Ph.D., director of the Laboratory of Thoracic Surgery at ...

Study reveals link between oil spill exposure and hematologic and hepatic toxicity

2013-09-17
Philadelphia, PA, September 17, 2013 – A new study reports that workers exposed to crude oil and dispersants used during the Gulf oil spill cleanup display significantly altered blood profiles, liver enzymes, and somatic symptoms compared to an unexposed control group. Investigators found that platelet counts were significantly decreased in the exposed group, while both hemoglobin and hematocrit levels were notably increased. Their findings, reported in The American Journal of Medicine, suggest that oil spill cleanup workers are at risk for developing hepatic or blood-related ...

Financial incentives motivate sedentary adults to exercise

2013-09-17
TORONTO, September 17, 2013 – A review study published today finds that financial incentives –as modest as $5 per week – can increase the amount of exercise people do. Lead author Marc Mitchell, University of Toronto PhD candidate and Cardiac Rehabilitation Supervisor at Toronto Rehab, worked under the leadership of University of Toronto exercise psychologist Guy Faulkner and exercise physiologist Jack Goodman to publish these findings in the September online publication of the American Journal of Preventive Medicine. The review study looked at 1,500 patients. "The ...

Online citizen scientists: Classify plankton images

2013-09-17
SEPTEMBER 17, 2013 (MIAMI, FL USA)—Today, an online citizen-science project launches called "Plankton Portal" was created by researchers at the University of Miami Rosenstiel School of Marine and Atmospheric Sciences (RSMAS) in collaboration with the National Oceanic and Atmospheric Administration (NOAA) and the National Science Foundation (NSF) and developers at Zooniverse.org Plankton Portal allows you to explore the open ocean from the comfort of your own home. You can dive hundreds of feet deep, and observe the unperturbed ocean and the myriad animals that inhabit the ...

Marine species distribution shifts reflect local climate conditions

2013-09-16
Climate change has resulted in shifts in where and at what depths many marine species are found. These shifts have not been uniform, and sometimes have occurred at different rates and in different ways than expected. The leading explanation for these changes has been biological differences among species, but a new study suggests that the local climatic conditions are more likely causing these shifts In a study published September 13 in the journal Science, researchers from the U.S. and Canada suggest that climate velocity – the rate and direction that climate shifts in ...

Can olive leaf extract attenuate lead-induced brain injury?

2013-09-16
In recent years, neurotoxicity from exposure to low levels of lead in the environment has become increasingly prevalent. Therefore, the discovery of herbs that have lead-eliminating properties without harmful side effects is essential for the management of lead poisoning. Preliminary studies by Yu Wang and colleagues from Longnan Teachers College have verified that olive leaf extract can protect the blood, spleen and hippocampus in lead-poisoned mice. However, little is known about the effects of olive leaf extract on lead-induced brain injury. A recent study from Yu Wang ...

Does rutaecarpine relieve cerebral ischemia reperfusion injury?

2013-09-16
Rutaecarpine, an active component of the traditional Chinese medicine Tetradium ruticarpum, has been shown to improve myocardial ischemia reperfusion injury, mainly focusing on calcitonin gene-based targets. Because both cardiovascular and cerebrovascular diseases are forms of ischemic vascular disease, they are closely related. A recent study reported by Chunlin Yan and colleagues from Hebei North University for the first time investigated the neuroprotective effects and mechanism of action of rutaecarpine on nerve function and learning and memory following cerebral ischemia ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] MicroRNA molecule found to be a potent tumor-suppressor in lung cancer